litlas
Log inCreate account

Mien‐Chie Hung

Active 1983–2025

Also published as
Mien-Chie Hung
406
Papers
86,429
Citations
160
h-index
390
i10-index

Citations

Citations per year for Mien‐Chie Hung1978: 1 citations1983: 2 citations1984: 3 citations1985: 11 citations1986: 39 citations1987: 77 citations1988: 65 citations1989: 50 citations1990: 69 citations1991: 51 citations1992: 66 citations1993: 50 citations1994: 55 citations1995: 60 citations1996: 59 citations1997: 90 citations1998: 96 citations1999: 158 citations2000: 260 citations2001: 328 citations2002: 429 citations2003: 477 citations2004: 463 citations2005: 608 citations2006: 548 citations2007: 633 citations2008: 695 citations2009: 694 citations2010: 887 citations2011: 940 citations2012: 889 citations2013: 888 citations2014: 866 citations2015: 834 citations2016: 790 citations2017: 826 citations2018: 853 citations2019: 2,778 citations2020: 3,414 citations2021: 3,539 citations2022: 3,143 citations2023: 2,635 citations2024: 3,803 citations2025: 2,045 citations2026: 60 citations1979–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 10,769 citing papers, 27.6% of this breakdownChina: 9,597 citing papers, 24.6% of this breakdownUnited Kingdom: 1,559 citing papers, 4% of this breakdownGermany: 1,379 citing papers, 3.5% of this breakdownItaly: 1,285 citing papers, 3.3% of this breakdownCanada: 1,039 citing papers, 2.7% of this breakdownJapan: 1,027 citing papers, 2.6% of this breakdownSouth Korea: 874 citing papers, 2.2% of this breakdownFrance: 872 citing papers, 2.2% of this breakdownIndia: 855 citing papers, 2.2% of this breakdownTaiwan: 817 citing papers, 2.1% of this breakdownSpain: 768 citing papers, 2% of this breakdown
0%27.6%Other 21%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology51.7%
  • Medicine37.5%
  • Immunology and Microbiology5.1%
  • Neuroscience1.2%
  • Engineering0.9%
  • Chemistry0.9%
  • Other2.7%

Topics

  • Cancer-related molecular mechanisms research2.8%
  • RNA modifications and cancer2.8%
  • Epigenetics and DNA Methylation2.7%
  • Cancer Immunotherapy and Biomarkers2.6%
  • Cancer Cells and Metastasis2.4%
  • HER2/EGFR in Cancer Research2.3%
  • Other84.4%

Coauthors

All papers

Open in search
  1. BAP1 links metabolic regulation of ferroptosis to tumour suppression

    Authors: Yilei Zhang, Jiejun Shi, Xiaoguang Liu, Feng Li, Zihua Gong, Pranavi Koppula, Kapil Sirohi, Xu Li, Yongkun Wei, Hyemin Lee, Li Zhuang, Gang Chen, Zhen‐Dong Xiao, Mien‐Chie Hung, Junjie Chen, Peng Huang, Wei Li, Boyi Gan - Nature Cell Biology 2018 cited by 1,032

  2. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis

    Authors: Junwei Hou, Rongce Zhao, Weiya Xia, Chiung-Wen Chang, Yun You, Jung-Mao Hsu, Lei Nie, Yeh Chen, Yu-Chuan Wang, Chunxiao Liu, Wei‐Jan Wang, Yun Wu, Baozhen Ke, Jennifer L. Hsu, Ke-Bin Huang, Zu Ye, Yi Yang, Xianghou Xia, Yintao Li, Chia‐Wei Li, Bin Shao, John A. Tainer, Mien‐Chie Hung - Nature Cell Biology 2020 cited by 1,009

  3. Mechanisms Controlling PD-L1 Expression in Cancer

    Authors: Jong‐Ho Cha, Li-Chuan Chan, Chia‐Wei Li, Jennifer L. Hsu, Mien‐Chie Hung - Molecular Cell 2019 cited by 1,050

  4. Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics

    Authors: Hirohito Yamaguchi, Jung-Mao Hsu, Wenhao Yang, Mien‐Chie Hung - Nature Reviews Clinical Oncology 2022 cited by 471

  5. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

    Authors: Chia‐Wei Li, Seung-Oe Lim, Weiya Xia, Heng‐Huan Lee, Li-Chuan Chan, Chu‐Wei Kuo, Kay‐Hooi Khoo, Shih-Shin Chang, Jong‐Ho Cha, Tae‐Wan Kim, Jennifer L. Hsu, Yun Wu, Jung-Mao Hsu, Hirohito Yamaguchi, Qingqing Ding, Yan Wang, Jun Yao, Cheng‐Chung Lee, Hsing‐Ju Wu, Ayşegül A. Şahin, James P. Allison, Dihua Yu, Gabriel N. Hortobágyi, Mien‐Chie Hung - Nature Communications 2016 cited by 1,110

  6. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

    Authors: Ri‐Yao Yang, Linlin Sun, Ching-Fei Li, Yuhan Wang, Jun Yao, Hui Li, Meisi Yan, Wei-Chao Chang, Jung-Mao Hsu, Jong‐Ho Cha, Jennifer L. Hsu, Cheng-Wei Chou, Xian Wen Sun, Yalan Deng, Chao‐Kai Chou, Dihua Yu, Mien‐Chie Hung - Nature Communications 2021 cited by 605

  7. Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

    Authors: Jong‐Ho Cha, Wenhao Yang, Weiya Xia, Yongkun Wei, Li-Chuan Chan, Seung‐Oe Lim, Chia-Wei Li, Tae‐Wan Kim, Shih-Shin Chang, Heng‐Huan Lee, Jennifer L. Hsu, Hung-Ling Wang, Chu‐Wei Kuo, Wei‐Chao Chang, Sirwan Hadad, Colin A. Purdie, Aaron McCoy, Shirong Cai, Yizheng Tu, Jennifer K. Litton, Elizabeth A. Mittendorf, Stacy Moulder, W. Fraser Symmans, Alastair M. Thompson, Helen Piwnica‐Worms, Chung‐Hsuan Chen, Kay‐Hooi Khoo, Mien‐Chie Hung - Molecular Cell 2018 cited by 758

  8. TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

    Authors: Zhou Jiang, Seung-Oe Lim, Meisi Yan, Jennifer L. Hsu, Jun Yao, Yongkun Wei, Shih-Shin Chang, Hirohito Yamaguchi, Heng‐Huan Lee, Baozhen Ke, Jung-Mao Hsu, Li-Chuan Chan, Gabriel N. Hortobágyi, Liuqing Yang, Chunru Lin, Dihua Yu, Mien‐Chie Hung - Journal of Clinical Investigation 2021 cited by 313

  9. Deubiquitination and Stabilization of PD-L1 by CSN5

    Authors: Seung-Oe Lim, Chia‐Wei Li, Weiya Xia, Jong‐Ho Cha, Li-Chuan Chan, Yun Wu, Shih-Shin Chang, Wan-Chi Lin, Jung-Mao Hsu, Yi‐Hsin Elsa Hsu, Tae‐Wan Kim, Wei-Chao Chang, Jennifer L. Hsu, Hirohito Yamaguchi, Qingqing Ding, Yan Wang, Yi Yang, Chung‐Hsuan Chen, Ayşegül A. Şahin, Dihua Yu, Gabriel N. Hortobágyi, Mien‐Chie Hung - Cancer Cell 2016 cited by 767

  10. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade

    Authors: Ying Zhu, Jing Yang, Da Xu, X.M. Gao, Ze Zhang, Jennifer L. Hsu, Chia‐Wei Li, Seung-Oe Lim, Yuan-Yuan Sheng, Yu Zhang, Jian-Hua Li, Qin Luo, Yan Zheng, Yue Zhao, Lu Lu, Hu-Liang Jia, Mien‐Chie Hung, Qiongzhu Dong, Lun‐Xiu Qin - Gut 2019 cited by 411

  11. Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1

    Authors: Chia‐Wei Li, Seung-Oe Lim, Ezra M. Chung, Yongsoo Kim, Andrew H Park, Jun Yao, Jong‐Ho Cha, Weiya Xia, Li-Chuan Chan, Tae‐Wan Kim, Shih-Shin Chang, Heng‐Huan Lee, Chao‐Kai Chou, Yen‐Liang Liu, Hsin‐Chih Yeh, Evan P. Perillo, Andrew K. Dunn, Chu‐Wei Kuo, Kay‐Hooi Khoo, Jennifer L. Hsu, Yun Wu, Jung-Mao Hsu, Hirohito Yamaguchi, Tzu-Hsuan Huang, Ayşegül A. Şahin, Gabriel N. Hortobágyi, Stephen Yoo, Mien‐Chie Hung - Cancer Cell 2018 cited by 618

  12. Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth

    Authors: Yi Yang, Chia‐Wei Li, Li-Chuan Chan, Yongkun Wei, Jung-Mao Hsu, Weiya Xia, Jong‐Ho Cha, Junwei Hou, Jennifer L. Hsu, Linlin Sun, Mien‐Chie Hung - Cell Research 2018 cited by 499

  13. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study

    Authors: Lili Feng, Zhenyu Liu, Chaofeng Li, Zhenhui Li, Xiaoying Lou, Lizhi Shao, Yunlong Wang, Yan Huang, Haiyang Chen, Xiaolin Pang, Shuai Liu, Fang He, Jian Zheng, Xiaochun Meng, Peiyi Xie, Guanyu Yang, Yi Ding, Mingbiao Wei, Jing‐Ping Yun, Mien‐Chie Hung, Weihua Zhou, Daniel Wahl, Ping Lan, Jie Tian, Xiang‐Bo Wan - The Lancet Digital Health 2021 cited by 321

  14. PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

    Authors: Shiping Jiao, Weiya Xia, Hirohito Yamaguchi, Yongkun Wei, Mei‐Kuang Chen, Jung-Mao Hsu, Jennifer L. Hsu, Wen-Hsuan Yu, Yi Du, Heng‐Huan Lee, Chia‐Wei Li, Chao‐Kai Chou, Seung-Oe Lim, Shih-Shin Chang, Jennifer K. Litton, Banu Arun, Gabriel N. Hortobágyi, Mien‐Chie Hung - Clinical Cancer Research 2017 cited by 975

  15. Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity

    Authors: Junwei Hou, Jung-Mao Hsu, Mien‐Chie Hung - Molecular Cell 2021 cited by 309

  16. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion

    Authors: Jung-Mao Hsu, Weiya Xia, Yi‐Hsin Elsa Hsu, Li-Chuan Chan, Wen-Hsuan Yu, Jong‐Ho Cha, Chun‐Te Chen, Hsin-Wei Liao, Chu‐Wei Kuo, Kay‐Hooi Khoo, Jennifer L. Hsu, Chia-Wei Li, Seung-Oe Lim, Shih-Shin Chang, Yi‐Chun Chen, Guo-xin Ren, Mien‐Chie Hung - Nature Communications 2018 cited by 433

  17. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis

    Authors: Daqian Xu, Zheng Wang, Yan Xia, Fei Shao, Weiya Xia, Yongkun Wei, Xinjian Li, Xu Qian, Jong-Ho Lee, Linyong Du, Yanhua Zheng, Guishuai Lv, Jia-Shiun Leu, Hongyang Wang, Dongming Xing, Tingbo Liang, Mien‐Chie Hung, Zhimin Lu - Nature 2020 cited by 360

  18. Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy

    Authors: Heng‐Huan Lee, Ying‐Nai Wang, Weiya Xia, Chia‐Hung Chen, Kun-Ming Rau, Leiguang Ye, Yongkun Wei, Chao‐Kai Chou, Shao‐Chun Wang, Meisi Yan, Chih‐Yen Tu, Te‐Chun Hsia, Shu‐Fen Chiang, K. S. Clifford Chao, Ignacio I. Wistuba, Jennifer L. Hsu, Gabriel N. Hortobágyi, Mien‐Chie Hung - Cancer Cell 2019 cited by 413

  19. IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion

    Authors: Li-Chuan Chan, Chia‐Wei Li, Weiya Xia, Jung-Mao Hsu, Heng‐Huan Lee, Jong‐Ho Cha, Hung-Ling Wang, Wenhao Yang, Er-Yen Yen, Wei-Chao Chang, Zhengyu Zha, Seung-Oe Lim, Yun‐Ju Lai, Chunxiao Liu, Jielin Liu, Qiongzhu Dong, Yi Yang, Linlin Sun, Yongkun Wei, Lei Nie, Jennifer L. Hsu, Hui Li, Qing‐Hai Ye, Manal M. Hassan, Hesham M. Amin, Ahmed O. Kaseb, Xin Lin, Shao‐Chun Wang, Mien‐Chie Hung - Journal of Clinical Investigation 2019 cited by 383

  20. Palmitoylation stabilizes PD-L1 to promote breast tumor growth

    Authors: Yi Yang, Jung-Mao Hsu, Linlin Sun, Li-Chuan Chan, Chia‐Wei Li, Jennifer L. Hsu, Yongkun Wei, Weiya Xia, Junwei Hou, Yufan Qiu, Mien‐Chie Hung - Cell Research 2018 cited by 276

  21. Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer

    Authors: Chenfang Dong, Tingting Yuan, Yadi Wu, Yifan Wang, Teresa W.‐M. Fan, Sumitra Miriyala, Yiwei Lin, Jun Yao, Jian Shi, Tiebang Kang, Pawel Lorkiewicz, Daret St. Clair, Mien‐Chie Hung, B. Mark Evers, Binhua P. Zhou - Cancer Cell 2013 cited by 823

  22. Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade

    Authors: Xiaoming Dai, Xia Bu, Yang Gao, Jianping Guo, Jia Hu, Cong Jiang, Zhao Zhang, Kexin Xu, Jinzhi Duan, Shaohui He, Jinfang Zhang, Lixin Wan, Tianjie Liu, Xiaobo Zhou, Mien‐Chie Hung, Gordon J. Freeman, Wenyi Wei - Molecular Cell 2021 cited by 248

  23. The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer

    Authors: Jennifer L. Hsu, Mien‐Chie Hung - Cancer and Metastasis Reviews 2016 cited by 443

  24. Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity

    Authors: Linlin Sun, Chia-Wei Li, Ezra M. Chung, Ri‐Yao Yang, Yong‐Soo Kim, Andrew H Park, Yun‐Ju Lai, Yi Yang, Yu-Han Wang, Jielin Liu, Yufan Qiu, Kay‐Hooi Khoo, Jun Yao, Jennifer L. Hsu, Jong‐Ho Cha, Li-Chuan Chan, Jung-Mao Hsu, Heng‐Huan Lee, Stephen Yoo, Mien‐Chie Hung - Cancer Research 2020 cited by 173